Public health & disease

Close-up of someone's eye

Egypt becomes world’s 27th nation to eliminate trachoma

By / / Good News For Humankind

In a historic public health victory, the World Health Organization (WHO) has verified that Egypt has eliminated trachoma as a public health problem. This achievement ends the scourge of the world’s leading infectious cause of blindness, which had been documented in the region for over 3,000 years. The success was driven by the rigorous SAFE strategy—surgery, antibiotics, facial cleanliness, and environmental improvement—and protects millions from preventable vision loss.

Syringe extracting from a vaccine vial

Malaria vaccine price cut set to protect 7 million more children by 2030

By / / Good News For Humankind

A landmark agreement between Gavi and UNICEF has secured a major price reduction for the R21 malaria vaccine, lowering the cost from $3.90 to under $3 per dose. This 25% price cut is expected to save $90 million, allowing for the purchase of 30 million additional doses. This financial breakthrough accelerates the goal of vaccinating 50 million children across Africa by 2030, providing a critical new tool to save lives and reduce the burden of this deadly disease.

Aerial view of Sydney, Australia

Sydney to ban gas and electrify all new big buildings

By / / Good News For Humankind

The City of Sydney has taken a pioneering step toward eliminating fossil fuels from its buildings. The council voted to mandate that all new major buildings must be built all-electric, effectively banning natural gas connections. This major policy shift is critical for accelerating the city’s transition to net-zero emissions. By removing indoor gas pollution, the mandate also creates healthier, safer urban environments for its residents.

Pancreatic cancer breath test

New pancreatic cancer breath test hailed as major breakthrough

By / / Good News For Humankind

A breakthrough in early cancer detection is offering crucial hope against pancreatic cancer. The NHS has launched a national validation trial involving over 6,000 patients to test a simple breathalyzer device. Developed by researchers at Imperial College London, this non-invasive test identifies unique chemical signatures of the disease. This pioneering diagnostic tool promises to increase the percentage of patients eligible for potentially life-saving surgery.

Male, Maldives

The Maldives becomes first country to eliminate mother-to-child transmission of HIV, syphilis & hepatitis B

By / / Good News For Humankind

The Maldives has achieved a major public health victory by eliminating mother-to-child transmission of HIV, syphilis, and Hepatitis B (HBV). This historic WHO-verified status makes the nation a global leader in maternal and child health. The success is rooted in universal antenatal screening and equitable access to medication across all islands. This achievement secures a healthier start for future generations and provides a powerful blueprint for eliminating other diseases globally.

African children

Niger becomes first African nation declared free from river blindness

By / / Good News For Humankind

This major public health triumph has eradicated onchocerciasis, or river blindness, in Niger. The nation is the first in Africa to achieve this World Health Organization-verified status. This victory eliminates a debilitating parasitic disease that had historically pushed populations away from fertile river valleys. The successful, multi-decade effort restores human dignity, unlocks agricultural land for economic development, and provides a powerful blueprint for eliminating other neglected tropical diseases across the continent.

Insulin pen

California to become U.S. first state to sell cheap insulin through state-backed program

By / / Good News For Humankind

California has achieved a major healthcare milestone by launching a groundbreaking initiative to provide affordable, state-backed insulin. The pioneering CalRx program is contracting with a generic manufacturer to produce the medication, which it will sell at near-cost prices. This action is expected to drastically lower costs for the nearly $3.2 million residents living with diabetes. By intervening in the market, the state affirms that essential, life-saving medication must be affordable, setting a powerful national precedent for health equity.

Brain x-rays

Scientists reverse Alzheimer’s in mice under breakthrough treatment

By / / Good News For Humankind

A breakthrough in neurological science is offering major hope against Alzheimer’s disease. An international research team successfully used a single-injection nanotherapy to reverse symptoms in mice. This treatment rapidly clears up to 50% of toxic amyloid proteins by rebooting the brain’s own natural clearance systems. This innovation, developed by the Institute for Bioengineering of Catalonia and West China Hospital of Sichuan University, shifts the focus from managing decline to restoring function, accelerating research toward a cure for this devastating disease.

Bacteria under microscope

Cholera vaccination campaign launched in Darfur to protect over 1.8 million people

By / / Good News For Humankind

A vital cholera vaccination campaign has been launched in Darfur, Sudan, aiming to protect over 1.86 million people. This urgent intervention is a major victory for global health, achieved despite the ongoing conflict and insecurity in the region. Humanitarian teams, led by the WHO and UNICEF, overcame immense logistical challenges to deliver millions of vaccine doses. This proactive measure is crucial for halting the spread of the country’s longest-recorded cholera outbreak and safeguarding the lives of highly vulnerable populations, especially young children.

Black and white illustration of human brain

U.K. scientists successfully treat Huntington’s disease for first time ever

By / / Good News For Humankind

A breakthrough gene therapy is offering unprecedented hope for families battling Huntington’s disease (HD), a fatal neurodegenerative disorder. Trial results show the one-time therapy successfully slowed disease progression by 75% in patients. This major victory, developed by scientists at University College London, is the first treatment to truly modify the disease’s course. It transforms a devastating, inherited diagnosis into a manageable condition, accelerating research for other neurological disorders like Alzheimer’s.